• USPh Q2 2026 net revenue rose 8.5% to $214.1 million; GAAP EPS fell to $0.25.
• GAAP net income attributable to shareholders dropped to $9.9 million; adjusted EBITDA edged up to $27 million.
• Physical therapy net revenue increased 8.4% to $182.4 million; margin narrowed 1.7 percentage points to 19.5%.
• Patient visits climbed 6.6% to 1,661,694; revenue per visit increased to $107.59 from Q2 2025.
• USPh reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million-$106 million; 31 hospital-affiliated clinics integrated, 39 more slated for Q3.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USPh - U.S. Physical Therapy Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260805033144) on August 05, 2026, and is solely responsible for the information contained therein.